| Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. |
2023-09-12 |
| Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. |
2023-09-11 |
| iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried. |
2023-09-05 |
| Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. |
2023-08-23 |
| Sophia Genetics S.A.. (8/22/23). "Press Release: Sophia Genetics Expands Relationship with Gustave Roussy". Boston, MA & Rolle. |
2023-08-22 |
| Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". |
2023-08-21 |
| Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". |
2023-08-21 |
| IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. |
2023-08-07 |
| Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen. |
2023-08-03 |
| Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. |
2023-07-24 |
| SGS S.A.. (7/18/23). "Press Release: SGS Appoints Géraldine Picaud as New Chief Financial Officer [Ad hoc announcement pursuant to Art. 53 LR]". |
2023-07-18 |
| High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. |
2023-07-14 |
| EG 427. (7/13/23). "Press Release: EG 427 Announces Final Series A Closing, Achieving €18 Million in Total Funds Raised". Paris. |
2023-07-13 |
| Abionyx Pharma S.A.. (7/13/23). "Press Release: Abionyx Pharma Announces the Appointment of Laurent Guerci as Chief Digital & Innovation Officer". Toulouse & Lakeland, MI. |
2023-07-13 |
| SparingVision S.A.S.. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. |
2023-07-12 |
| Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-Based Therapeutics and In Vivo Reprogramming". London. |
2023-07-12 |
| ECBF Management GmbH. (7/11/23). "Press Release: Aphea.Bio, a Portfolio Company of VC Fund ECBF, Raises a Groundbreaking Series C Round of 70 Million Euros". Luxembourg. |
2023-07-11 |
| Carbios S.A.. (7/11/23). "Press Release: Carbios Announces the Success of Its Capital Increase with Preferential Subscription Rights of Approximately 141 Million Euros, the Largest on Euronext Growth since 2015". Clermont-Ferrand. |
2023-07-11 |
| Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. |
2023-07-11 |
| Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA. |
2023-07-10 |
| Flash Therapeutics S.A.S.. (7/6/23). "Press Release: Flash Therapeutics Appoints Jérôme Bédier as Président to Accelerate Its Biopharmaceutical CDMO Business Development". Toulouse. |
2023-07-06 |
| Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]". |
2023-07-03 |
| NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. |
2023-07-03 |
| Exeliom Biosciences S.A.S.. (6/30/23). "Press Release: Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million ($26 Million) to Progress the Clinical Development of its Lead Candidate in Immuno-Oncology and Infectious |
2023-06-30 |
| Gleamer S.A.S.. (6/28/23). "Press Release: Gleamer Raises €27 Million in Series B Funding Round to Expand Its AI Solutions Portfolio and Speed up International Expansion". Paris. |
2023-06-28 |
| Carthera S.A.S.. (6/27/23). "Press Release: Carthera Closes €37.5M Series B Funding Round". Paris. |
2023-06-27 |
| Astraveus S.A.S.. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. |
2023-06-27 |
| SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA. |
2023-06-22 |
| Carbios S.A.. (6/22/23). "Press Release: Carbios Announces the Launch of a Rights Issue Totalling around €122 Million, Likely to Be Increased to around €141 Million if the Extension Clause Is Fully Exercised". Clermont-Ferrand. |
2023-06-22 |
| MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. |
2023-06-21 |
| Nuage Therapeutics. (6/20/23). "Press Release: Nuage Therapeutics Raises €12M in Seed Financing Led by Sofinnova Partners and Asabys". Barcelona. |
2023-06-20 |
| AAVantgarde Bio S.r.l.. (6/6/23). "Press Release: AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic". Milan. |
2023-06-06 |
| Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen. |
2023-06-05 |
| BC Platforms AG. (6/1/23). "Press Release: BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data". Zurich. |
2023-06-01 |
| Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. |
2023-05-17 |
| Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. |
2023-05-15 |
| Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg. |
2023-05-12 |
| DiogenX S.A.S.. (5/10/23). "Press Release: DiogenX Raises €27.5M Series A Financing to Advance Its First-in-Class Regenerative Treatment for Type 1 Diabetes Towards Clinical Development". Marseille. |
2023-05-10 |
| Alia Therapeutics S.r.l.. (5/9/23). "Press Release: Alia Therapeutics Appoints Adel Nada as Independent Board Director". Milan. |
2023-05-09 |
| Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg. |
2023-05-05 |
| Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan. |
2023-05-05 |
| Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA. |
2023-04-26 |
| Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin. |
2023-04-18 |
| Alia Therapeutics S.r.l.. (4/17/23). "Press Release: Alia Therapeutics Secures €4.4 Million Seed Financing Extension Led by Sofinnova Partners". Milan. |
2023-04-17 |
| Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. |
2023-04-13 |
| Calida Therapeutics S.A.S.. (4/6/23). "Press Release: French Biotech Calida Therapeutics Launches with Seed Funding, Leveraging US Academic Research in Thrombo-inflammatory Disorders". Paris. |
2023-04-06 |
| Mithra Pharmaceuticals S.A.. (4/4/23). "Press Release: Mithra Announces the Appointment of David H Solomon as Chief Executive Officer". Ličge. |
2023-04-04 |
| Scorpion Therapeutics, Inc.. (4/4/23). "Press Release: Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer". Bost |
2023-04-04 |
| AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". |
2023-04-03 |
| Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen. |
2023-03-31 |
| Galapagos N.V.. (3/30/23). "Press Release: Galapagos and Novalix Enter into an Integrated Drug Discovery Collaboration". Mechelen & Strasbourg. |
2023-03-30 |
| Deepc GmbH. (3/28/23). "Press Release: Digital Medicine Pioneer, Deepc, Announces €12 Million Series A Round Led by Sofinnova Partners". |
2023-03-28 |
| Sofinnova Partners. (3/28/23). "Press Release: BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures to Unlock Drug-bacteria Interactions". London. |
2023-03-28 |
| Sofinnova Partners. (3/28/23). "Press Release: Kiro, Cutting-edge Digital Medicine Company, Raises €13.8 Million in Series A Funding Led by Sofinnova Partners". Paris. |
2023-03-28 |
| Sofinnova Partners. (3/28/23). "Press Release: Sofinnova Partners Launches Digital Medicine Strategy. VC to Back Startups at the Intersection of Biology, Data and Computation". Paris. |
2023-03-28 |
| ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. |
2023-03-27 |
| Lys Therapeutics S.A.S.. (3/15/23). "Press Release: Lys Therapeutics Secures Funding from The Michael J. Fox Foundation to Accelerate the Development of Its Drug Candidate in Parkinson’s Disease". Lyon & Caen. |
2023-03-15 |
| Mediar Therapeutics Inc.. (3/15/23). "Press Release: Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies". Cambridge, MA. |
2023-03-15 |
| AlgoTherapeutix S.A.S.. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes. |
2023-03-14 |
| Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ. |
2023-03-13 |
| Iktos S.A.S.. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne. |
2023-03-09 |
| Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel. |
2023-03-07 |
| AdBio Partners S.A.S.. (2/23/23). "Press Release: AdBio Partners Appoints Geoffroy de Ribains as Managing Partner". Paris. |
2023-02-23 |
| Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris. |
2023-02-16 |
| Avilar Therapeutics, Inc.. (2/16/23). "Press Release: Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders". Waltham, MA. |
2023-02-16 |
| Biper Therapeutics S.A.S.. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg. |
2023-02-14 |
| Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse. |
2023-02-10 |
| Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg. |
2023-02-07 |
| Ariceum Therapeutics GmbH. (2/1/23). "Press Release: Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer". Berlin. |
2023-02-01 |
| Toulouse White Biotech (TWB). (1/31/23). "Press Release: TWB Announces a Strategic Partnership with Canadian Multinational Premier Tech". Toulouse. |
2023-01-31 |
| Sensorion S.A.. (1/31/23). "Press Release: Sensorion and Eveon Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments into the Inner Ear". Montpellier. |
2023-01-31 |
| TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. |
2023-01-23 |
| InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. |
2023-01-19 |
| PinCell S.r.l.. (1/19/23). "Press Release: PinCell Announces the Development of a Key Transgenic Mouse Model and the Appointment of Dr. Antonino Amato as CEO". Milan. |
2023-01-19 |
| BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. |
2023-01-17 |
| InDevR, Inc.. (1/17/23). "Press Release: InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux". Boulder, CO. |
2023-01-17 |
| Sanofi S.A.. (1/11/23). "Press Release: Sanofi Ventures Announces Multi-year Capital Commitment from Sanofi, Increasing Evergreen Fund to $750M". Paris. |
2023-01-11 |
| CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. |
2023-01-10 |
| Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. |
2023-01-10 |
| Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. |
2023-01-09 |
| AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline". |
2023-01-09 |
| Volta Medical. (1/5/23). "Press Release: Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced". Marseille. |
2023-01-05 |
| ErVaccine Technologies S.A.. (1/5/23). "Press Release: ErVaccine Closes a €4.5 Million Financing Round and Prepares to Start Clinical Trial with Its First Therapeutic Cancer Vaccine in 2023". Lyon. |
2023-01-05 |
| Cellectis S.A.. (12/29/22). "Press Release: Mayflower Bioventures Launches Its First Spin-Out, Primera Therapeutics, in Strategic Collaboration with Cellectis to Develop a Gene Editing Platform to Treat Mitochondrial Diseases". New York, NY. |
2022-12-29 |
| Cellectis S.A.. (12/28/22). "Press Release: Cellectis Secures a €40 Million Credit Facility from the European Investment Bank to Support its Research, Development and Innovation Activities". Paris. |
2022-12-28 |
| Atara Biotherapeutics, Inc.. (12/20/22). "Press Release: Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty". Thousand Oaks, CA. |
2022-12-20 |
| Atara Biotherapeutics, Inc.. (12/19/22). "Press Release: Atara Biotherapeutics’ Ebvallo (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD". Thousand Oaks, CA & Castres. |
2022-12-19 |
| Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. |
2022-12-17 |
| Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg. |
2022-12-15 |
| Oncodesign Precision Medicine S.A.. (12/15/22). "Press Release: OPM and Servier Launch "FederAidd", an International Virtual Campus for Open Innovation to Accelerate and Make the Drug Discovery Process more Reliable Thanks to Artificial Intelligence". Pa |
2022-12-15 |
| Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
| MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. |
2022-11-30 |
| Biomemory S.A.S.. (11/28/22). "Press Release: Biomemory Raises 5 Million Euros Seed Investment to Advance Its Cutting-edge DNA Digital Data Storage Solution". Paris. |
2022-11-28 |
| Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. |
2022-11-22 |
| European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". |
2022-11-18 |
| Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. |
2022-11-17 |
| Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. |
2022-11-17 |
| Lys Therapeutics S.A.S.. (11/14/22). "Press Release: Lys Therapeutics Announces a Seed Round of 5.5 Million Euros to Prepare Future Clinical Studies for Its First-in-class Monoclonal Antibody targeting neurovascular and neurodegenerative disorders". Lyon |
2022-11-14 |
| Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. |
2022-11-14 |
| Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. |
2022-11-11 |
![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
